Fluid retention: FDA reporting patterns
50,170 FDA FAERS reports mention Fluid retention. 35,988 reports have a serious outcome flag.
Medicines named as suspect
- Ambrisentan: 4,597 reports
- Treprostinil: 4,145 reports
- Macitentan: 2,943 reports
- Sodium Chloride: 2,639 reports
- Calcium Chloride: 2,568 reports
- Magnesium Chloride: 2,562 reports
- Sodium Lactate: 2,561 reports
- Valsartan: 2,560 reports
- Dextrose: 2,417 reports
- Sacubitril: 2,195 reports
- Adalimumab: 1,549 reports
- Bosentan: 1,216 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.